Owners
History
2023: Creation of a center for the development of high-tech medicine
Rosatom is creating a center for cyclotron technologies for the development of high-tech medicine. The press service of the state corporation spoke about this project at the end of September 2023.
The center will be established on the basis of JSC "V.G. Khlopin Radium Institute" (part of the scientific division of ROSATOM State Corporation). JSC NIIEFA (also part of Rosatom) has concluded an agreement with the institute for the manufacture and supply of the latest cyclotron complex in 2026. The installation of SS-30/15 with regulated proton energy from 15 to 30 megaelectronvolts and the intensity of the output beams up to 400 microamperes will become the most powerful in Russia (among domestic devices).
The cyclotron will be used to produce isotopes, including generator type, which are widely used in nuclear medicine to diagnose socially significant diseases, primarily cardiological and oncological. The cyclotron parameters will allow simultaneous operation on two target devices with a beam output intensity of up to 200 μA per target.
As the deputy scientific director of NIIEFA JSC Yuri Gavrish explained, the uniqueness of this cyclotron is determined by its peripheral devices. As part of the contract, NIIEFA specialists will develop new target devices that will allow the most efficient use of high-current cyclotron beams and ensure maximum production of radioisotope products.
So, according to Gavrish, a robotic system for changing target devices will be used in the accelerator for the Radium Institute. This will significantly reduce the area required to accommodate the equipment and speed up the process of replacing one target with another with minimal switching of equipment in the cyclotron. In terms of its parameters, the cyclotron can SS-30/15 be used not only for the development of isotopes, but also in borneutrontic capture, and simply in neutron therapy, he added.[1]
Notes
The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |